Manus Bio

company

About

Manus Bio makes nature accessible and affordable for a growing society.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$75M
Industries
Biopharma,Biotechnology,Food and Beverage
Founded date
Jan 1, 2011
Number Of Employee
51 - 100
Operating Status
Active

Manus Bio makes nature accessible and affordable for a growing society. Making nature accessible and affordable for a growing society.It is estimated that the world’s population will increase by more than 35% by 2050, reaching 9 billion people. Crop production will need to more than double in order to feed these people and meet the consumer needs of a developing world. With very little land remaining for agricultural expansion, they as a society need to find ways to maximize the use of their world’s resources.

Plants produce a variety of rare natural products which are used in their daily lives as flavors, fragrances, food ingredients, cosmetics, vitamins, pharmaceuticals and agricultural chemicals. They strive to reduce their dependence on land- and resource-intensive practices by recreating natural processes through biotechnology.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$76.77M
Manus Bio has raised a total of $76.77M in funding over 2 rounds. Their latest funding was raised on Nov 17, 2020 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 17, 2020 Series B $75M 1 Detail
Aug 30, 2017 Grant $1.21M 1 National Science Foundation Detail
Jun 19, 2013 Grant $225K 1 National Science Foundation Detail
Dec 18, 2012 Grant $150K 1 National Science Foundation Detail
May 24, 2012 Grant $180K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
4
2
Manus Bio is funded by 2 investors. National Science Foundation and Ethos Family Office are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
Ethos Family Office Series B